Tolerability & Safety of Premarin Vaginal Cream in Indian Postmenopausal Women

• Status: Completed
• Trial end date: 2006-10-01
• Target enrollment: 0
• Participant gender: Female

Summary

This post-marketing study will provide local safety and tolerance data on the use of Premarin® vaginal cream.

• Accepts Healthy Volunteers?: No

Details

• Lead Sponsor: Wyeth is now a wholly owned subsidiary of Pfizer
• Treatments: Estrogens; Estrogens, Conjugated (USP)

Criteria

Inclusion Criteria:

• Patients in whom Premarin vaginal cream is indicated.

• In the opinion of the investigator, sufficient intelligence and motivation for the patient to continue throughout the study.

• Provide signed informed consent.

Exclusion Criteria:

• Patients not willing to give informed consent.